Replies to post #22430 on BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Nice post Gaboy. Ditto on Gold. Can anyone say manipulation??? Give me a break. This company is about to break out. I've been thru this before and came out the other side way ahead of the game with no where near the potential of Biocurex. Dr Moro is going to succeed. Just spend 5 minutes talking to him and you know you will be more than impressed with his knowledge, drive, dedication and determination to succeed. He is a winner and I am excited being on the threshold of greatness. ISOBM is around the corner and as usual IMO there will be something new and exciting. I would be shocked if he did not attend. If he does Gold, do you still think he still his days are numbered? Gold the more you post, the more positives we find. Thanks. You are actually swaying more investors to see the true potential of recaf. The near term up and down in share price is due to manipulation, and Mata has been all over this ruse. He has spoiled their gig and they will eventually have to retreat.

[Gold Seeker]

Gaboy, the following are trials that have been run, in progress or plan to be run by Inverness. Where is RECAF?

Rank Status Study
1 Completed BRAIN (Biomarker Rapid Assessment of Ischemic iNjury) Conditions: Stroke; Stroke Mimic(Conditions Presenting With Stroke-Like Conditions)
Intervention:

2 Completed Evaluation of Neutrophil Gelatinase-associated Lipocalin (NGAL) in Early and Evolving Acute Kidney Injury Condition: Kidney Failure, Acute
Intervention:

3 Terminated Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS) Condition: Acute Coronary Syndrome
Intervention: Device: Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP)

4 Terminated Multi-Marker INDex for the Risk Assessment of Sepsis in the Emergency departmenT (MINDSET) Condition: Sepsis
Intervention: Procedure: Blood samples collected

5 Active, not recruiting Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy Condition: Cardiovascular Surgery With Coronary Angiography
Intervention:

6 Completed SHORTness of Breath In the Emergency Department (SHORTIE) Conditions: Acute Myocardial Infarction; Heart Failure; Pulmonary Embolism
Intervention: Device: Triage Profiler S.O.B. Panel

7 Not yet recruiting Evaluation of Serial Troponin and Cardiac Multimarkers at the Point of Care in the Emergency Department Conditions: Acute Myocardial Infarction; Chest Pain; Acute Coronary Syndrome
Intervention:

8 Recruiting Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home Condition: Heart Failure
Intervention:

9 Not yet recruiting Evaluation of the Accuracy of the INRatio Prothrombin Time (PT) Monitoring System With a New Test Strip for the Oral Anticoagulation Therapy Patient in the Presence of Heparin and Low Molecular Weight Heparin (e.g., Enoxaparin or Dalteparin) Condition: Coagulation
Intervention:

10 Recruiting Neutrophil Gelatinase-associated Lipocalin (NGAL) Evaluation in Emergency Department (ED) All-Comers Condition: Acute Kidney Injury
Intervention:

11 Terminated Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT II) Condition: Heart Failure
Intervention: Device: Triage BNP Test

12 Recruiting Neutrophil Gelatinase-Associated Lipcalin (NGAL) Evaluation Along With B-Type Natriuretic Peptide in Acutely Decompensated HF Condition: Acute Decompensated Heart Failure
Intervention:

13 Recruiting Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement Condition: Acute Coronary Syndrome (ACS)
Intervention: Device: Biomarkers

14 Terminated Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT) Condition: Heart Failure
Intervention: Device: Triage® B-Type Natriuretic Peptide (BNP) Test

15 Recruiting Clinical Performance Evaluation of the Cholestech LDX Cardiac hsCRP Test (CLEAR) Condition: Cardiovascular Disease
Intervention:

16 Recruiting Triage Now: an Observational, Prospective Multimarker Study of Biomarkers in Patients Presenting With Chest Pain Conditions: Acute Coronary Syndrome; Myocardial Infarction
Intervention:

17 Not yet recruiting Accuracy of the Pima™ CD4 Test for Enumeration of CD4+ T-Cell Counts Conditions: HIV Infection; AIDS
Intervention:

18 Active, not recruiting Correlations Between BNP & Dry Weight, and Between Troponin & Mortality, in Hemodialysis Patients Conditions: Kidney Failure, Chronic; Heart Failure, Congestive
Intervention:

19 Recruiting B-Type Natriuretic Peptide for the Management of Weaning Condition: Respiratory Insufficiency
Interventions: Procedure: BNP-guided weaning; Procedure: Standard physician-directed weaning

20 Active, not recruiting Effect of Rosiglitazone Versus Placebo on Cardiovascular Performance and Myocardial Triglyceride Condition: Diabetes Mellitus, Type 2
Intervention: Drug: rosiglitazone